Nancy Gillett is VP at CHARLES RIVER LABORATORIES INTERNATIONAL INC (CRL). They have made 33 open-market trades across 1 company since 2007, most recently 2016-03-02.
CIK 0001100682
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 33 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| CRL | 28,111 | $8.4M |
Shares reported on the most recent Form 4, priced at the 2016-03-04 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CRL | SELL | 2016-03-02 | 2016-03-04 | $75.49 | $406K | -4.2% | +7.0% | +17.6% |
| CRL | SELL | 2016-03-02 | 2016-03-04 | $75.21 | $773K | -4.2% | +7.0% | +17.6% |
| CRL | SELL | 2016-03-02 | 2016-03-04 | $75.83 | $62K | -4.2% | +7.0% | +17.6% |
| CRL | SELL | 2016-03-02 | 2016-03-04 | $75.00 | $542K | -4.2% | +7.0% | +17.6% |
| CRL | SELL | 2016-02-29 | 2016-02-29 | $73.50 | $268K | -0.3% | +2.3% | +16.5% |
| CRL | SELL | 2016-02-12 | 2016-02-17 | $71.90 | $971K | +0.3% | +0.9% | +14.4% |
| CRL | SELL | 2015-03-02 | 2015-03-03 | $76.72 | $336K | -6.2% | -1.2% | -1.2% |
| CRL | SELL | 2015-02-27 | 2015-03-03 | $76.95 | $213K | -6.2% | -1.2% | -1.2% |
| CRL | SELL | 2015-02-25 | 2015-02-27 | $76.80 | $874K | -6.2% | -1.2% | -1.2% |
| CRL | SELL | 2015-02-25 | 2015-02-27 | $76.59 | $460K | -6.2% | -1.2% | -1.2% |
| CRL | SELL | 2015-02-24 | 2015-02-26 | $76.12 | $382K | -6.2% | -1.2% | -1.2% |
| CRL | SELL · 10b5-1 | 2014-11-03 | 2014-11-05 | $64.91 | $2.3M | -6.2% | -1.2% | -1.2% |
| CRL | SELL · 10b5-1 | 2014-10-30 | 2014-11-03 | $65.00 | $69K | -6.2% | -1.2% | -1.2% |
| CRL | SELL | 2014-03-06 | 2014-03-07 | $58.36 | $590K | -6.2% | -1.2% | -1.2% |
| CRL | SELL | 2014-03-04 | 2014-03-06 | $58.98 | $799K | -6.2% | -1.2% | -1.2% |
| CRL | SELL | 2014-02-28 | 2014-03-04 | $59.11 | $266K | -6.2% | -1.2% | -1.2% |
| CRL | SELL | 2014-02-28 | 2014-03-04 | $59.61 | $341K | -6.2% | -1.2% | -1.2% |
| CRL | SELL | 2014-02-28 | 2014-03-04 | $60.08 | $43K | -6.2% | -1.2% | -1.2% |
| CRL | SELL | 2014-02-27 | 2014-02-28 | $60.00 | $240K | -6.2% | -1.2% | -1.2% |
| CRL | SELL | 2014-02-20 | 2014-02-24 | $58.96 | $236K | -6.2% | -1.2% | -1.2% |
| CRL | SELL | 2013-11-13 | 2013-11-15 | $51.00 | $1.3M | -6.2% | -1.2% | -1.2% |
| CRL | SELL | 2013-03-08 | 2013-03-12 | $42.66 | $1.4M | -6.2% | -1.2% | -1.2% |
| CRL | SELL | 2013-03-08 | 2013-03-12 | $42.71 | $141K | -6.2% | -1.2% | -1.2% |
| CRL | SELL | 2013-03-07 | 2013-03-11 | $41.73 | $276K | -6.2% | -1.2% | -1.2% |
| CRL | SELL | 2013-03-07 | 2013-03-11 | $41.72 | $768K | -6.2% | -1.2% | -1.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.